Syncona Share Discussion Threads

[audigger] 09/8/2018 07:06

All looks good. hopefully share price will now stabilise. No objections to a quick return to 270 though!

[rambutan2] 06/8/2018 19:26

Slow releasing the June nav, and associated big write up. As of today, at current price of $24, the stake is worth £252m.

(Following the IPO (at $17), Syncona retains a stake of 32.7% in Autolus (amounting to 13,592,098 ordinary shares), which was valued at GBP268.5 million at the close of
business on 25 June 2018.)

And here's AUTL's recent presentation:

[kristini2] 28/7/2018 14:20

i sold here recently having bought at 2.12 - just seems to be well ahead on the NAV so i'm hoping to add if it drops back to circa 2.20 ish

[kristini2] 28/7/2018 14:19

yes sir.....
it was tipped in the mail a month ago at 2.08 and i bought in recently

[brexitplus] 23/7/2018 09:11

Does anyone here hold Arix Bioscience?

[rambutan2] 13/7/2018 21:18

Below, the headline from an article worth reading on Citywire re Numis note:

Numis' healthcare and life sciences analysts this week formally started coverage of Syncona with a target share price of 320p, compared to last night’s closing share price of 269p.

[audigger] 09/7/2018 21:42

Like the definition! And I agree with IT that this is one for the bottom drawer.

[ltinvestor] 09/7/2018 18:20

Put this share in a bottom drawer locked away.Best kept secret on Advfn !!

[alan@bj] 09/7/2018 17:44

Doozy - “something outstanding or unique of its kind”.

[audigger] 09/7/2018 17:21

Proving to be a bit of a doozy is this (technical term I know!). Would be nice to hit 300p in July

[luxaeterna1] 02/7/2018 10:15

From Blue Earth's website:

hxxp://www.blueearthdiagnostics.com/blue-earth-diagnostics-appoints-iason-sp-z-o-o-to-manufacture-and-distribute-axumin-fluciclovine-18f-in-poland/

"Blue Earth Diagnostics now has six manufacturing and distribution agreements for Axumin in place covering seventeen European countries."

Note: BED is mainly owned by SYNC and is the first profitable company built and reported last month.

[morgank] 25/6/2018 18:42

Nightstar up 8% on Nasdaq today could help tomorrows SP

[morgank] 24/6/2018 20:41

I make it about 12.3p / share above what was expected @IPO price of $17, we did get 19p rise at the close Friday so maybe priced in

[morgank] 24/6/2018 20:26

Looks like a pop on the open Monday although we did get an 8.4% gain late Friday, not sure if IPO trading had begun at LSE market close

[brexitplus] 22/6/2018 18:03

Added on Wednesday. Good decision.

[ltinvestor] 22/6/2018 17:04

Autolus presently $26 up 56%

[acuere] 22/6/2018 08:35

That top end placing price suggests there is strong demand for Autolus. Institutions that couldn’t get all the Autolus shares they wanted might view Syncona as a cheap/less risky way of access to Autolus potential.

[ltinvestor] 22/6/2018 08:27

Looks like institutional buying on the back of the ipo news..

[ltinvestor] 22/6/2018 07:40

Autolus placing at $17 ( higher end) with listing on Nasdaq later today.Interesting to note that Syncona have maintained their % holding....

[brexitplus] 19/6/2018 08:26

Plenty going on here. Two new investments plus today’s increased investment in Freeline. And a strategic theme in gene therapy.

[rambutan2] 15/6/2018 03:37

The results presentation:



And the results themselves:

[audigger] 14/6/2018 12:06

Indeed all is looking good and whilst its a little out of the limelight the price remains a bargain in my opinion. I added today and plan to add more should there be any dips.

[ltinvestor] 14/6/2018 11:11

Nitestar awarded Rmat which is the road to “accelerated approval”

[brexitplus] 14/6/2018 07:36

Totally agree. The approach and choice of investments is excellent. Very professional.

[ltinvestor] 14/6/2018 07:24

I am quite amazed by the lack of Pi interest in Syncona.Todays results give a snapshot of the potential here with regard to their investments in the field of gene therapy....